Daunorubicin
Records for this ingredient, by country (identity only).
ATC L01DB02 · 13 markets · 38 records
US 6 records · 2 shown of 2
Only this ingredient
- 5 mg per mL / per unit basis not statedinjectionManufacturer: Hikma Pharmaceuticals USA I… ×2Manufacturer: Hisun Pharmaceuticals USA, …、Manufacturer: Meitheal Pharmaceuticals In…
Combination products containing this ingredient
- 44 mg/20 mLinjection CombinationCytarabine 100 mg/20 mL + Daunorubicin 44 mg/20 mLVYXEOS
CA 5 records · 3 shown of 3
Only this ingredient
- 5 mg/1 mLliquidDaunorubicin HydrochlorideDAUNORUBICIN INJECTABLE
- 20 mgpowderCERUBIDINE
Combination products containing this ingredient
- 44 mgpowder CombinationCytarabine 100 mg + Daunorubicin 44 mgVYXEOS
AU 5 records · 2 shown of 2
Only this ingredient
- 20 mg per mL / per unit basis not statedinjectionPFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial
Combination products containing this ingredient
- 44 mg per mL / per unit basis not statedinjection CombinationCytarabine 100 mg + Daunorubicin 44 mgVYXEOS
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CN 5 records · 1 shown of 1
Only this ingredient
- 20 mg per mL / per unit basis not statedinjectionManufacturer: 山东新时代药业有限公司 ×2Manufacturer: 深圳万乐药业有限公司、Manufacturer: 瀚晖制药有限公司
GB 3 records · 2 shown of 2
Only this ingredient
- 20 mg per mL / per unit basis not statedinjectionManufacturer: A A H Pharmaceuticals LtdManufacturer: Zentiva Pharma UK Ltd
Combination products containing this ingredient
- 44 mg per mL / per unit basis not statedinjection CombinationCytarabine 100 mg + Daunorubicin 44 mgVyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials
ES 2 records · 2 shown of 2
Only this ingredient
- 20 mg per mL / per unit basis not statedinjectionDAUNOBLASTINA
Combination products containing this ingredient
- 44 mg per mL / per unit basis not statedinjection CombinationCitarabina 100 mg + Daunorubicin 44 mgVYXEOS LIPOSOMAL
JP 2 records · 1 shown of 1
Only this ingredient
- 20 mg per mL / per unit basis not statedinjectionダウノマイシン静注用20mg
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 1 shown of 1
Only this ingredient
- 21.4 mg per mL / per unit basis not statedinjectionCERUBIDINE 20 mg, poudre pour solution pour perfusion
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
SG 1 records · 1 shown of 1
Only this ingredient
- 20 mg/vial per mL / per unit basis not statedinjectionDAUNOCIN FOR INJECTION 20 mg/vial
MX 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 shown of 1
Only this ingredient
- 20 mg per mL / per unit basis not statedinjectionDAUNOBLASTINA 20MG FOR唐黴素注射劑
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
DOXOrubicin) FDA recommends tall-man lettering for this pair; check the ingredient, not the name. All pairsDiscontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.